Vanguard Group »

Alzamend Neuro Inc Com New 2025 shares owned by Vanguard Group

Quarter-by-quarter ownership of Alzamend Neuro Inc Com New 2025 (ALZN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Alzamend Neuro Inc Com New 2025

Tip: Access up to 7 years of quarterly data

All positions including Alzamend Neuro Inc Com New 2025 held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alzamend Neuro Inc Com New 2025 by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $52k 22k 2.38

More positions owned by Vanguard Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Oracle Corporation (ORCL)

View all positions for Vanguard Group

Top funds holding Alzamend Neuro Inc Com New 2025

DRW Holdings
Vanguard Group
Geode Capital Management
Hartland & Co
UBS Group
Tower Research Capital
BlackRock
SBI Securities
Harbor Investment Advisory
Activest Wealth Management

View all funds holding Alzamend Neuro Inc Com New 2025